← Back to Search

Cyanoacrylate glue for Central Line Infection

N/A
Waitlist Available
Led By Marianne Garland, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* All patients admitted to the 9 North intensive coronary care unit (ICCU) at NewYork-Presbyterian Morgan Stanley Children's Hospital greater than 35 weeks of corrected gestational age who have a PICC line placed by a NICU provider.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up until picc line removal (approximately 12 weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if using medical glue at the spot where a tube is inserted into a baby's vein can help keep the bandage in place longer and prevent the tube from moving. It focuses on newborns in NICU who have delicate skin and tend to move a lot. The glue acts like a strong adhesive, making the bandage stick better and last longer.

Eligible Conditions
  • Central Line Infection
  • Newborn Illness

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~until picc line removal (approximately 12 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and until picc line removal (approximately 12 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Duration of longevity of PICC line dressing
Secondary study objectives
PICC line migration incidences

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cyanoacrylate Glue GroupExperimental Treatment2 Interventions
This group will receive a few drops of cyanoacrylate glue on PICC line site prior to application of usual standard film dressing over the PICC line site.
Group II: Control GroupActive Control1 Intervention
This group will be received the current standard of care (SOC) dressing method for PICC lines.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard transparent film dressing
2022
N/A
~40
Cyanoacrylate glue
2020
N/A
~630

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,486 Previous Clinical Trials
2,663,148 Total Patients Enrolled
Marianne Garland, MDPrincipal InvestigatorMorgan Stanley Children's Hospital of NYP
1 Previous Clinical Trials
50 Total Patients Enrolled
~9 spots leftby Nov 2025